Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes

European Journal of Immunology

Volumn 29, Issue 12, 1999, Pages 3995-4001

  Subklewe, Marion ^a   Chahroudi, Ann ^a   Bickham, Kara ^a   Larsson, Marie ^a   Kurilla, Michael G ^b,c   Bhardwaj, Nina ^a   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c DUPONT COMPANY   (United States)

Author keywords

CD8+ T cell; Dendritic cell; EBNA 3; ELISPOT; Epstein Barr virus

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; VIRUS ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MONOCYTE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS LATENCY; VIRUS RECOMBINANT;

ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HERPESVIRUS 4, HUMAN; HUMANS; INTERFERON TYPE II; RECOMBINATION, GENETIC; VACCINIA VIRUS; VIRUS LATENCY;

EID: 0032709798     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199912)29:12<3995::AID-IMMU3995>3.0.CO;2-E     Document Type: Article

References (18)

1. Rickinson, A. B. and Moos, D. J., Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 1997. 15: 405-431.
2. Kieff, E., Epstein-Barr virus and its replication. Lippincott-Raven, Philadelphia, 1996, 2342-2396.
3. Deeg, H. J. and Socié, G., Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood 1998. 91: 1833-1844.
4. Rooney, C. M., Smith, C. A., Ng, C. Y. C., Loftin, S., Li, C., Krance, R. A., Brenner, M. K. and Heslop, H. E., Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995. 345: 9-13.
5. Rooney, C. M., Smith, C. A., Ng, C. Y. C., Loftin, S. K., Sixbey, J. W., Gan, Y., Srivastava, D.-K., Browman, L. C., Krance, R. A., Brenner, M. K. and Heslop, H. E., Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998. 92: 1549-1555.
6. + T cells in chronically infected HIV-1 positive individuals. AIDS 1999. 13: 767-777.
7. + memory T cells. J. Exp. Med. 1997. 186: 859-865.
8. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. and Rickinson, A. B., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J. Exp. Med. 1992. 176: 157-168.
9. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. and Ahmed, R., Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection, Immunity 1998. 8: 177-187.
10. McCutcheon, M., Wehner, N., Wensky, A., Kushner, M., Doan, S., Hsiao, L., Calabresi, P., Ha, T., Tran, T. V., Tate, K. M., Winkelhake, J. and Spack, E. G., A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods 1997. 210: 149-166.
11. Schmittel, A., Keilholz, U. and Scheibenbogen, C., Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J. Immunol. Methods 1997. 210: 167-174.
12. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
13. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 1998. 95: 270-275.
14. + T cells specific for EBV in healthy virus carriers. J. Immunol. 1998. 162: 1827-1835.
15. Apollini, A., Moss, D., Stumm, R., Burrows, S., Suhrbier, A., Misko, T., Schmidt, C. and Sculley, T., Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus. Eur. J. Immunol. 1992. 22: 183-189.
16. Reddy, A., Sapp, M., Feldmann, M., Subklewe, M. and Bhardwaj, N., A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 1997. 90: 3640-3646.
17. Murray, R. J., Kurilla, M. G., Griffin, H. M., Brooks, J. M., Mackett, M., Arrand, J. R., Rowe, M., Burrows, S. R., Moss, D. J., Kieff, E. and Rickinson, A. B., Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc. Natl. Acad. Sci. USA 1990. 87: 2906-2910.
18. Subklewe, M., Charoudi, A., Schmaljohn, A., Kurilla, M. G., Bhardwaj, N. and Steinman, R., Induction of Epstein-Barr Virus-Specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus. Blood 1999. 94: 1372-1381.